Overexpression of the Atypical Protein Kinase C ζ Reduces Topoisomerase II Catalytic Activity, Cleavable Complexes Formation, and Drug-induced Cytotoxicity in Monocytic U937 Leukemia Cells-Reference-Cited by-同舟云学术

Overexpression of the Atypical Protein Kinase C ζ Reduces Topoisomerase II Catalytic Activity, Cleavable Complexes Formation, and Drug-induced Cytotoxicity in Monocytic U937 Leukemia Cells

Published:2002-08 Issue:35 Volume:277 Page:31407-31415
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Plo Isabelle,Hernandez Hélène,Kohlhagen Glenda,Lautier Dominique,Pommier Yves,Laurent Guy

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference39 articles.

1. Nuclear topoisomerase II levels correlate with the sensitivity of mammalian cells to intercalating agents and epipodophyllotoxins.

2. Resistance of Mammalian Tumor Cells to Inhibitors of DNA Topoisomerase II

3. Effect of casein kinase II-mediated phosphorylation on the catalytic cycle of topoisomerase II. Regulation of enzyme activity by enhancement of ATP hydrolysis.

4. Protein kinase C modulates the catalytic activity of topoisomerase II by enhancing the rate of ATP hydrolysis: evidence for a common mechanism of regulation by phosphorylation

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulation of topoisomerase II stability and activity by ubiquitination and SUMOylation: clinical implications for cancer chemotherapy;Molecular Biology Reports;2021-09

2. The interplay between DNA topoisomerase 2α post-translational modifications and drug resistance;Cancer Drug Resistance;2020

3. TOP2B: The First Thirty Years;International Journal of Molecular Sciences;2018-09-14

4. Mdm2 selectively suppresses DNA damage arising from inhibition of topoisomerase II independent of p53;Oncogene;2017-07-10

5. Modulators of Atypical Protein Kinase C as Anticancer Agents;Annual Reports in Medicinal Chemistry;2014